Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : Amazon.com, Inc. (AMZN) -- Ignore unavailable to you. Want to Upgrade?

To: Robert Rose who wrote (102974)	5/8/2000 4:02:00 PM
From: allen menglin chen	Read Replies (1) \| Respond to of 164685

Nice to see u coming back Robert -- hope u are fresh after your vacation. I bot CRA from 65-71 10+ days ago, and holding to sell in the CRA's news later this week -- buy and hold CRA ST :) I bot CEGE, GENE and VICL as well. I will add CEGE and GENE on the dips later this week. Once CRA news out, CEGE and GENE should jump big along w/ other gene stocks.

To: Robert Rose who wrote (102974)	5/8/2000 5:51:00 PM
From: allen menglin chen	Respond to of 164685

Robert, William brought us CRA here first. You better ask him how CRA would be in the longer term -- I think Willaim is really buy and hold CRA for the long term. Based on today's news, at least DoubleTwist is planning to charge any private company for its human gene info $650,000 per yr. And CRA can easily do the same. How many pharmaceutical and biotechnology companies in the world would pay for such info? ~10,000? And don't forget the public universities... Message 13635226